Trial Profile
Safety of Sildenafil in Premature Infants at Risk of Bronchopulmonary Dysplasia
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Feb 2024
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary) ; Sildenafil (Primary)
- Indications Bronchopulmonary dysplasia
- Focus Adverse reactions
- Acronyms SIL02
- 20 Feb 2024 Planned End Date changed from 28 Mar 2024 to 22 Sep 2024.
- 20 Feb 2024 Planned primary completion date changed from 15 Feb 2024 to 11 Aug 2024.
- 16 May 2023 Planned End Date changed from 30 Sep 2024 to 28 Mar 2024.